Literature DB >> 15358834

Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate.

Kartiki V Desai1, Aleksandra M Michalowska, Paturu Kondaiah, Jerrold M Ward, Joanna H Shih, Jeffrey E Green.   

Abstract

Understanding androgen regulation of gene expression is critical for deciphering mechanisms responsible for the transition from androgen-responsive (AR) to androgen-independent (AI) prostate cancer (PCa). To identify genes differentially regulated by androgens in each prostate lobe, the rat castration model was used. Microarray analysis was performed to compare dorsolateral (DLP) and ventral prostate (VP) samples from sham-castrated, castrated, and testosterone-replenished castrated rats. Our data demonstrate that, after castration, the VP and the DLP differed in the number of genes with altered expression (1496 in VP vs. 256 in DLP) and the nature of pathways modulated. Gene signatures related to apoptosis and immune response specific to the ventral prostate were identified. Microarray and RT-PCR analyses demonstrated the androgen repression of IGF binding protein-3 and -5, CCAAT-enhancer binding protein-delta, and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) genes, previously implicated in apoptosis. We show that PTEN protein was increased only in the luminal epithelial cells of the VP, suggesting that it may be a key mediator of VP apoptosis in the absence of androgens. The castration-induced immune/inflammatory gene cluster observed specifically in the VP included IL-15 and IL-18. Immunostaining of the VP, but not the DLP, showed an influx of T cells, macrophages, and mast cells, suggesting that these cells may be the source of the immune signature genes. Interestingly, IL-18 was localized mainly to the basal epithelial cells and the infiltrating macrophages in the regressing VP, whereas IL-15 was induced in the luminal epithelium. The VP castration model exhibits immune cell infiltration and loss of PTEN that is often observed in progressive PCa, thereby making this model useful for further delineation of androgen-regulated gene expression with relevance to PCa.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358834     DOI: 10.1210/me.2004-0033

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  11 in total

1.  Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas.

Authors:  Mehrnoosh Saghizadeh; Andrei A Kramerov; Jian Tajbakhsh; Annette M Aoki; Charles Wang; Ning-Ning Chai; Julia Y Ljubimova; Takako Sasaki; Gabriel Sosne; Marc R J Carlson; Stanley F Nelson; Alexander V Ljubimov
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

2.  Combination therapy with a second-generation androgen receptor antagonist and a metastasis vaccine improves survival in a spontaneous prostate cancer model.

Authors:  Andressa Ardiani; Benedetto Farsaci; Connie J Rogers; Andy Protter; Zhimin Guo; Thomas H King; David Apelian; James W Hodge
Journal:  Clin Cancer Res       Date:  2013-09-18       Impact factor: 12.531

3.  Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization.

Authors:  Yi T Koh; Andrew Gray; Sean A Higgins; Bolyn Hubby; W Martin Kast
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

4.  Gene expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17beta-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats.

Authors:  Neville N C Tam; Carol Ying-Ying Szeto; Maureen A Sartor; Mario Medvedovic; Shuk-Mei Ho
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

Review 5.  Sex differences in autoimmune disease from a pathological perspective.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Noel R Rose
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

6.  Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry.

Authors:  G Rastrelli; L Giovannini; A E Calogero; D Gianfrilli; E Serra; A Pizzocaro; V A Giagulli; G Motta; G Vancieri; A Sperandio; S Andò; R Selice; G Luca; F Cocchiara; D Canale; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-04-01       Impact factor: 4.256

Review 7.  Sex differences in inflammation during atherosclerosis.

Authors:  DeLisa Fairweather
Journal:  Clin Med Insights Cardiol       Date:  2015-04-19

8.  Microarray analysis of cell cycle gene expression in adult human corneal endothelial cells.

Authors:  Binh Minh Ha Thi; Nelly Campolmi; Zhiguo He; Aurélien Pipparelli; Chloé Manissolle; Jean-Yves Thuret; Simone Piselli; Fabien Forest; Michel Peoc'h; Olivier Garraud; Philippe Gain; Gilles Thuret
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

9.  Transcription factors involved in prostate gland adaptation to androgen deprivation.

Authors:  Rafaela Rosa-Ribeiro; Umar Nishan; Ramon Oliveira Vidal; Guilherme Oliveira Barbosa; Leonardo Oliveira Reis; Carlos Lenz Cesar; Hernandes F Carvalho
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

10.  Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?

Authors:  Anita Mangia; Concetta Saponaro; Alessandro Vagheggini; Giuseppina Opinto; Matteo Centonze; Chiara Vicenti; Ondina Popescu; Maria Pastena; Francesco Giotta; Nicola Silvestris
Journal:  Cancers (Basel)       Date:  2019-09-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.